Methyl (2R,5S)-5-aminopiperidine-2-carboxylate dihydrochloride

Catalog No. :
ACQROJ034
CAS No. :
2940875-67-0
Molecular Formula :
C7H16Cl2N2O2
Molecular Weight :
231.12

IUPAC Name:methyl (2R,5S)-5-aminopiperidine-2-carboxylate dihydrochloride

Methyl (2R,5S)-5-aminopiperidine-2-carboxylate dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$586.00Login to see priceIn stockInquiry
250mg95%$780.00Login to see priceIn stockInquiry
500mg95%$1039.00Login to see priceIn stockInquiry
1g95%$1387.00Login to see priceIn stockInquiry
5g95%$5269.00Login to see priceInquiryInquiry
10g95%$8956.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (2R,5S)-5-aminopiperidine-2-carboxylate dihydrochloride
IUPAC Namemethyl (2R,5S)-5-aminopiperidine-2-carboxylate dihydrochloride
Molecular FormulaC7H16Cl2N2O2
Molecular Weight231.12
SMILESO=C([C@@H]1NC[C@@H](N)CC1)OC.[H]Cl.[H]Cl
InChI KeyKJCRLAZNZKYKIR-KXSOTYCDSA-N
Synonym2-Piperidinecarboxylic acid, 5-amino-, methyl ester, hydrochloride (1:2), (2R,5S)-
CAS No.2940875-67-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQROJ034 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWRMC079 route compound structure diagram
    ACWRMC07967515-76-8 In Stock
  2. Then
  3. ACQROJ034 route product structure diagram
    ACQROJ0342940875-67-0 In Stock
Inquiry

2. ACQROJ034 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQROJ034 route product structure diagram
    ACQROJ0342940875-67-0 In Stock
Inquiry

Comments (0)